ReproSil Chiral is a column series from Dr. Maisch HPLC GmbH developed for the separation of enantiomers and other chiral isomers using high-performance liquid chromatography (HPLC). These columns are based on high-purity, fully porous silica, coated or covalently bonded with chiral selectors such as amylose, cellulose, or cyclodextrin derivatives. ReproSil Chiral columns provide high stereoselectivity, robust retention, and reproducible resolution for a broad range of chiral compounds.
They are suitable for use in both normal-phase and polar organic or reversed-phase modes, depending on the selector and application.
ReproSil Chiral columns from Dr. Maisch HPLC GmbH offer precise and reliable enantiomer separations – ideal for laboratories focused on chiral HPLC, enantioselective method development, and regulatory testing.
| Particle Sizes | 3 – 20 µm |
|---|---|
| Phases/Modifications | α1-acid glycoprotein, β-Cyclodextrin, 3-(Phenylcarbamat)-Cellulose, Human serum albumin, L-Prolin, L-Hydroxy-Prolin, N-(3,5-Dinitrobenzoyl)-D-Phenylglycin, N-(3,5-Dinitrobenzoyl)-L-Leucin, N-(3,5-Dinitrobenzoyl)-L-Phenylglycin, Teicoplanin Aglycon, Teicoplanin, Tris-(3,5-dimethylphenyl)carbamat-Amylose, Tris-(S)-α-methylbenzylcarbamat-Amylose, Tris-Benzoat-Cellulose, Tris-(4-methylphenyl)carbamat-Cellulose, Tris-(4-methylbenzoyl)carbamate-Cellulose, Tris-(3,5-dimethylphenyl)carbamat-Cellulose, Tris-(3,5-dichlorophenyl)carbamat-Cellulose, Tris-(3-chlorophenyl)carbamat-Amylose, Tris-(3-chloro-4-methylphenyl)carbamat-Amylose, Tris-(4-chloro-3-methylphenyl)carbamat-Cellulose, Tris-(3-chloro-4-methylphenyl)carbamat-Cellulose, Tris-(4-chlorophenyl)carbamat-Cellulose, Tris-(5-chloro-2-methylphenyl)carbamat-Amylose |
| Pore Sizes | 100 Å, 300 Å, 1 000 Å |
| Surface Areas | 30 – 350 m²/g |
Silica-based chiral phases with various selector types
Excellent enantioselectivity and resolution
Compatible with normal-phase, polar organic, and RP eluents
Suitable for method development, QC, and regulatory environments
Manufactured and quality-assured by Dr. Maisch HPLC GmbH
Enantiomeric purity testing of chiral pharmaceuticals
Separation of stereoisomers and racemic mixtures
Chiral method development in drug discovery
Chiral QC and compliance with regulatory guidelines